Get started
ESPERION THERAPEUTESPERION THERAPEUTESPERION THERAPEUT

ESPERION THERAPEUT

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

0ET chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪365.82 M‬CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.872CHF
Net income (FY)
‪−176.17 M‬CHF
Revenue (FY)
‪97.95 M‬CHF
Shares float
‪154.83 M‬
Beta (1Y)
4.17

About Esperion Therapeutics, Inc.

Sector
Health Technology
CEO
Sheldon L. Koenig
Headquarters
Ann Arbor
Website
esperion.com
Employees (FY)
240
Founded
1998
FIGI
BBG00LVD9YR7
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0ET is 2.175 CHF — it has decreased by 54.70% in the past 24 hours. Watch ESPERION THERAPEUT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ESPERION THERAPEUT stocks are traded under the ticker 0ET.
0ET stock has fallen by 54.70% compared to the previous week, the month change is a 54.70% fall, over the last year ESPERION THERAPEUT has showed a 54.70% decrease.
We've gathered analysts' opinions on ESPERION THERAPEUT future price: according to them, 0ET price has a max estimate of 14.51 CHF and a min estimate of 2.63 CHF. Watch 0ET chart and read a more detailed ESPERION THERAPEUT stock forecast: see what analysts think of ESPERION THERAPEUT and suggest that you do with its stocks.
0ET reached its all-time high on Aug 10, 2021 with the price of 13.060 CHF, and its all-time low was 2.175 CHF and was reached on May 7, 2024. View more price dynamics on 0ET chart.
See other stocks reaching their highest and lowest prices.
0ET stock is 120.74% volatile and has beta coefficient of 4.17. Track ESPERION THERAPEUT stock price on the chart and check out the list of the most volatile stocks — is ESPERION THERAPEUT there?
Today ESPERION THERAPEUT has the market capitalization of ‪365.82 M‬, it has increased by 3.79% over the last week.
Yes, you can track ESPERION THERAPEUT financials in yearly and quarterly reports right on TradingView.
ESPERION THERAPEUT is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
0ET earnings for the last quarter are 0.31 CHF per share, whereas the estimation was 0.04 CHF resulting in a 598.27% surprise. The estimated earnings for the next quarter are −0.16 CHF per share. See more details about ESPERION THERAPEUT earnings.
ESPERION THERAPEUT revenue for the last quarter amounts to ‪124.25 M‬ CHF despite the estimated figure of ‪75.72 M‬ CHF. In the next quarter revenue is expected to reach ‪42.50 M‬ CHF.
0ET net income for the last quarter is ‪55.05 M‬ CHF, while the quarter before that showed ‪−47.44 M‬ CHF of net income which accounts for 216.04% change. Track more ESPERION THERAPEUT financial stats to get the full picture.
No, 0ET doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has 240.00 employees. See our rating of the largest employees — is ESPERION THERAPEUT on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ESPERION THERAPEUT EBITDA is ‪−19.40 M‬ CHF, and current EBITDA margin is −133.58%. See more stats in ESPERION THERAPEUT financial statements.
Like other stocks, 0ET shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ESPERION THERAPEUT stock right from TradingView charts — choose your broker and connect to your account.